本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Terns Pharmaceuticals, Inc.

7.16
-0.0900-1.24%
成交量:39.43万
成交额:283.03万
市值:6.27亿
市盈率:-6.87
高:7.32
开:7.24
低:7.07
收:7.25
52周最高:11.40
52周最低:1.87
股本:8,751.10万
流通股本:5,715.62万
量比:0.76
换手率:0.69%
股息:- -
股息率:- -
每股收益(TTM):-1.0419
每股收益(LYR):-1.1175
净资产收益率:-35.02%
总资产收益率:-23.97%
市净率:2.05
市盈率(LYR):-6.41

数据加载中...

2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

重要事件披露

Form 8-K - Current report
2024/01/25

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/15

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/14

重要事件披露

Form 8-K - Current report
2023/10/11

重要事件披露

Form 8-K - Current report
2023/10/04

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/08

重要事件披露

Form 8-K - Current report
2023/08/03

重要事件披露

Form 8-K - Current report
2023/07/29

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/06/29

SEC问询函

Form CORRESP - Correspondence
2023/06/27

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/06/15

重要事件披露

Form 8-K - Current report
2023/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/15

重要事件披露

Form 8-K - Current report
2023/05/15

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/05/15

重要事件披露

Form 8-K - Current report